MAXIMUS, Inc. (NYSE:MMS) General Counsel David Francis sold 3,600 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $64.50, for a total transaction of $232,200.00. Following the transaction, the general counsel now owns 10,017 shares of the company’s stock, valued at $646,096.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
David Francis also recently made the following trade(s):
- On Friday, November 17th, David Francis sold 1,373 shares of MAXIMUS stock. The shares were sold at an average price of $65.35, for a total transaction of $89,725.55.
Shares of MAXIMUS, Inc. (NYSE MMS) opened at $66.88 on Thursday. MAXIMUS, Inc. has a fifty-two week low of $57.12 and a fifty-two week high of $72.71. The company has a current ratio of 2.57, a quick ratio of 2.57 and a debt-to-equity ratio of 0.01. The stock has a market cap of $4,261.69, a price-to-earnings ratio of 20.55, a PEG ratio of 2.17 and a beta of 1.21.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date is Wednesday, February 14th. MAXIMUS’s dividend payout ratio is currently 5.36%.
MMS has been the subject of a number of research analyst reports. Zacks Investment Research downgraded shares of MAXIMUS from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. Canaccord Genuity reaffirmed a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. Finally, Maxim Group reaffirmed a “hold” rating and set a $69.00 price objective (up from $66.00) on shares of MAXIMUS in a report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $66.60.
Several hedge funds and other institutional investors have recently bought and sold shares of MMS. Zeke Capital Advisors LLC bought a new stake in MAXIMUS in the fourth quarter worth $222,000. Millennium Management LLC bought a new stake in MAXIMUS in the fourth quarter worth $1,259,000. Meadow Creek Investment Management LLC lifted its stake in MAXIMUS by 24.6% in the fourth quarter. Meadow Creek Investment Management LLC now owns 8,942 shares of the health services provider’s stock worth $640,000 after purchasing an additional 1,768 shares during the last quarter. HPM Partners LLC lifted its stake in MAXIMUS by 217.4% in the fourth quarter. HPM Partners LLC now owns 19,302 shares of the health services provider’s stock worth $1,382,000 after purchasing an additional 13,220 shares during the last quarter. Finally, Stone Ridge Asset Management LLC bought a new stake in MAXIMUS in the fourth quarter worth $1,683,000. 95.55% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “MAXIMUS, Inc. (MMS) General Counsel Sells $232,200.00 in Stock” was reported by Markets Daily and is owned by of Markets Daily. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.themarketsdaily.com/2018/02/15/maximus-inc-mms-general-counsel-sells-232200-00-in-stock.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.